Research and Development

The Research and Development team at Elypta focuses on advancing the company's metabolism-based liquid biopsy platform. They conduct cutting-edge research to identify metabolic biomarkers, develop and optimize diagnostic assays, and support clinical trials aimed at early cancer detection and monitoring. The team collaborates closely to ensure the technology meets stringent scientific and regulatory standards for in vitro diagnostics.